Cesar Cobaleda
banner
cjchcm.bsky.social
Cesar Cobaleda
@cjchcm.bsky.social
Biologist. Scientist. Curious. Researcher in rare diseases, cancer, hematopoiesis, epigenetics and bioinformatics, at CBM (CSIC)
Reposted by Cesar Cobaleda
📢¡Oferta de trabajo en el CBM!
El grupo de César Cobaleda busca postdoc para estudiar cómo se origina la leucemia infantil (B-ALL).
💡 Proyecto “la Caixa” Research Health 2025
🧬 Modelos murinos, epigenética, célula única
📅 Deadline: 5 dic 2025
www.cbm.uam.es/index.php/jo...
@cjchcm.bsky.social
Molecular Mechanisms of Childhood Leukemia Development - Centro de Biología Molecular Severo Ochoa
Job Description We are seeking a highly motivated postdoctoral researcher to join our laboratory to study the early steps of development of childhood B-cell Acute Lymphoblastic Leukemia (B-ALL). The p...
www.cbm.uam.es
November 12, 2025 at 7:44 PM
Reposted by Cesar Cobaleda
On #WorldBlood#CancerDay, let’s remember those affected and raise awareness about these diseases. Explore the main types of blood cancer and how they impact the body 👇

🔗 https://bit.ly/4kkBfvA

#HemeSky #MedSky #HemeOnc
May 28, 2025 at 5:01 PM
Reposted by Cesar Cobaleda
📣 We are super happy to share our new preprint!
We show how an imbalance between replication and transcription elongation rates can be uncoupled genome-wide without replicative stress 1/3
May 16, 2025 at 1:32 PM
Once you have enough knowledge of the literature in your research field, you realize you’ll never have enough knowledge of the literature in your research field.
May 15, 2025 at 11:11 AM
Reposted by Cesar Cobaleda
I am not necessarily against the initiative, but would a chimpanzee with 20 gene edits be human?

If you lined up a dire wolf genome with a gray wolf genome there would be millions of differences. These individuals seem optimistically 1/100,000th dire wolf. (No paper or preprint available though).
It's not a dire wolf. It's a gray wolf clone with 20 dire-wolf gene edits, and with some dire wolf traits. And here's my story! Gift link: www.nytimes.com/2025/04/07/s...
April 7, 2025 at 7:07 PM
Reposted by Cesar Cobaleda
Meinrad Busslinger, Emeritus Senior Group Leader at the IMP, received the Silver Medal for Meritorious Service to Vienna for his outstanding scientific achievements & key role in establishing the IMP and Vienna BioCenter. 🎖️👏

Read more: www.imp.ac.at/news/article...

@viennabiocenter.bsky.social
January 28, 2025 at 3:37 PM
Reposted by Cesar Cobaleda
We used to hear the term "tired blood." [Geritol]
Now it's tired proteins. Proteolethargy. Reduced protein mobility as an underpinning for chronic diseases
www.cell.com/cell/abstrac...
November 27, 2024 at 7:39 PM
Reposted by Cesar Cobaleda
In the end, it comes down to whether one believes the system generally allocates resources in ways that predict rather than fuel success. Between the tails of the distribution, I don’t think it does.
November 28, 2024 at 4:47 PM